妖姬直播

Is "therapeutic inertia" to blame?

Starting monoclonal antibody therapy during childhood reduced long-term disability

Arimoclomol (Miplyffa) greenlit for ultra-rare genetic disorder

Liver toxicity may still be a concern

Patients with high NfL at disease onset may benefit from high-efficacy treatments

Triptans are efficacious and underused, researchers say

Analysis looks at pooled data of 17,000 MS trial participants

News and commentary from the world of neurology and neuroscience

Findings suggest a pathway for plastic fragments to enter the brain

Research could provide clues about disorders like postpartum depression

Access to advanced tools must be equitable

In his new book, Theodore Schwartz, MD, immerses readers in the story of brain surgery

News and commentary from the world of neurology and neuroscience

Regulatory, policy requirements not met, agency says